Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Acquires 168,472 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 168,472 shares of the stock in a transaction on Monday, December 15th. The shares were purchased at an average price of $0.42 per share, with a total value of $70,758.24. Following the acquisition, the chief executive officer directly owned 6,628,457 shares in the company, valued at $2,783,951.94. This represents a 2.61% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas bought 56,080 shares of Cosmos Health stock. The shares were purchased at an average price of $0.68 per share, with a total value of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.62 per share, for a total transaction of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The stock was acquired at an average price of $0.65 per share, for a total transaction of $40,049.10.

Cosmos Health Stock Up 20.8%

Shares of NASDAQ COSM opened at $0.50 on Wednesday. The business has a 50-day moving average of $0.76 and a two-hundred day moving average of $0.72. The company has a market capitalization of $17.53 million, a price-to-earnings ratio of -0.67 and a beta of 5.34. Cosmos Health Inc. has a 1 year low of $0.28 and a 1 year high of $1.32. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.99 and a quick ratio of 0.84.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The business had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. On average, analysts forecast that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Armistice Capital LLC increased its holdings in Cosmos Health Inc. (NASDAQ:COSM) by 156.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,917,710 shares of the company’s stock after acquiring an additional 1,168,884 shares during the quarter. Armistice Capital LLC owned approximately 7.03% of Cosmos Health worth $836,000 at the end of the most recent quarter. 12.61% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on COSM. Wall Street Zen raised shares of Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.